Health

New mothers’ placenta could help reduce brain injury in other





The placenta from mothers of healthy newborns could one day be used to reduce brain injury in growth-restricted babies, according to University of Queensland research.

Dr Julie Wixey from UQ’s Centre for Clinical Research said the study found stem cells sourced from a healthy placenta may reduce damaging inflammation in these babies after only three days.

There is currently no treatment to protect the brains of a growth-restricted baby.

Up to 50 per cent of them have long term issues ranging from mild learning and behavioral disorders all the way through to cerebral palsy.

We know there’s inflammation in the brain and it doesn’t cease once these babies are born.

Our study has shown we could reduce inflammation and ongoing brain injury by treating these newborns on the day they’re born using a combination of two types of stem cells – endothelial colony forming cells and mesenchymal stromal cells – isolated from a healthy human placenta.”

Dr Julie Wixey, UQ’s Centre for Clinical Research

About 32 million growth-restricted babies are born around the world each year, with around 10 per cent of newborns in Australia affected.

These babies fail to grow normally in the womb, often because they haven’t received enough nutrients and oxygen from the placenta.

“Our research has found after just three days, the combination stem cell therapy not only reduced inflammation but also, importantly, appeared to repair damaged blood vessels in the brain in animal models,” Dr Wixey said.

“We’re really excited by the outcomes of this study and we hope it’ll improve these babies’ lives long term.”

The patent technique for harvesting stem cells from the placenta was co-invented by UQ’s Professor Kiarash Khosrotehrani and Dr Jatin Patel – now at the Queensland University of Technology (QUT).

“This has been a fantastic collaborative study and demonstrates the exciting potential of stem cell therapy in the near future in treating unwell babies,” Dr Patel said.

“We are now working towards scaling up our patented stem cell technology, that will result in greater quantities of cells to drive and expand the preclinical animal studies with the aim of progressing towards a human trial.”

The researchers will now investigate the longer-term outcomes of the combination stem cell treatment.

Source:

The University of Queensland

Journal reference:

Chand, K.K., et al. (2021) Combination of human endothelial colony-forming cells and mesenchymal stromal cells exert neuroprotective effects in the growth-restricted newborn. npj Regenerative Medicine. doi.org/10.1038/s41536-021-00185-5.

Read The Full Article Here

This Small Moment of Inclusivity Had a Big Impact
UKIE’s Shameful Advice to Parents Condoning Child Gambling
SAT: Why Do We Let a Number Take On so
Kerry Godliman On Being A “Good” Parent
I gained 100 pounds with gestational diabetes—despite throwing up constantly
letrozole tablets use 2.5 mg uses fast pregnancy tips in
Olivia Munn’s Mother’s Day Was Absolute Mom Goals
Safe Exercises to Try During the Second Trimester of Pregnancy
Baby Crawling – How and When The Parenting Basics
Do babies need to crawl?
TRYING BEST PARENTING LIFE HACKS-Smart Tips for Parents -NO MORE
Crying, Cooing, Communication: Baby’s First Year
Raising Children with Bipolar Disorder: One Mother’s Journey
My Child, His Imaginary Friend and I…
Principles for Raising a Child or Teen with ADHD with
Health-Tips for Raising Healthy Kids
Monkeypox
Recall Alert: Peanut Butter
Boosters Advised For 5-11 y/o
Investigating incidence and clinical features of post-acute sequelae of COVID-19
Child Development: Are You Anxious About Autistic Risks?
Autism: Tools To Adapt Yourself To Your Child’s Emotions And Unexpressed Requests
TASTE SAFE SENSORY ACTIVITIES FOR BABIES AND TODDLERS // DIY
How to Draw a Bee
Infant Science and Art Activity at Bright Horizons
Best Spraygrounds and Splash Pads on Long Island